nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Epirubicin—pancreatic cancer	0.138	0.174	CbGbCtD
Saxagliptin—ABCC1—Irinotecan—pancreatic cancer	0.134	0.17	CbGbCtD
Saxagliptin—ABCC1—Docetaxel—pancreatic cancer	0.0981	0.124	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—pancreatic cancer	0.0731	0.0926	CbGbCtD
Saxagliptin—CYP3A5—Tamoxifen—pancreatic cancer	0.0646	0.0819	CbGbCtD
Saxagliptin—CYP3A5—Erlotinib—pancreatic cancer	0.0549	0.0696	CbGbCtD
Saxagliptin—CYP3A5—Irinotecan—pancreatic cancer	0.0496	0.0629	CbGbCtD
Saxagliptin—CYP3A5—Docetaxel—pancreatic cancer	0.0364	0.0461	CbGbCtD
Saxagliptin—CYP3A5—Sunitinib—pancreatic cancer	0.0362	0.0459	CbGbCtD
Saxagliptin—CYP3A4—Tamoxifen—pancreatic cancer	0.0252	0.0319	CbGbCtD
Saxagliptin—CYP3A4—Erlotinib—pancreatic cancer	0.0214	0.0271	CbGbCtD
Saxagliptin—CYP3A4—Irinotecan—pancreatic cancer	0.0193	0.0245	CbGbCtD
Saxagliptin—CYP3A4—Docetaxel—pancreatic cancer	0.0142	0.018	CbGbCtD
Saxagliptin—CYP3A4—Sunitinib—pancreatic cancer	0.0141	0.0179	CbGbCtD
Saxagliptin—CYP3A4—Doxorubicin—pancreatic cancer	0.0106	0.0134	CbGbCtD
Saxagliptin—DPP4—Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)—PCSK1—pancreatic cancer	0.00574	0.15	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.00476	0.124	CbGpPWpGaD
Saxagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—PCSK1—pancreatic cancer	0.00424	0.111	CbGpPWpGaD
Saxagliptin—DPP4—Incretin synthesis, secretion, and inactivation—PCSK1—pancreatic cancer	0.00377	0.0985	CbGpPWpGaD
Saxagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—GCG—pancreatic cancer	0.00223	0.0582	CbGpPWpGaD
Saxagliptin—DPP4—Incretin synthesis, secretion, and inactivation—GCG—pancreatic cancer	0.00198	0.0517	CbGpPWpGaD
Saxagliptin—ABCC1—Cobalamin (Cbl, vitamin B12) transport and metabolism—PRSS1—pancreatic cancer	0.00177	0.0461	CbGpPWpGaD
Saxagliptin—DPP4—Peptide hormone metabolism—PCSK1—pancreatic cancer	0.00128	0.0334	CbGpPWpGaD
Saxagliptin—Nasopharyngitis—Sunitinib—pancreatic cancer	0.00123	0.0071	CcSEcCtD
Saxagliptin—Infestation—Erlotinib—pancreatic cancer	0.00122	0.00707	CcSEcCtD
Saxagliptin—Infestation NOS—Erlotinib—pancreatic cancer	0.00122	0.00707	CcSEcCtD
Saxagliptin—Urinary tract infection—Tamoxifen—pancreatic cancer	0.0012	0.00694	CcSEcCtD
Saxagliptin—Pancreatitis—Sunitinib—pancreatic cancer	0.00116	0.00673	CcSEcCtD
Saxagliptin—Sinusitis—Tamoxifen—pancreatic cancer	0.00116	0.0067	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Sunitinib—pancreatic cancer	0.0011	0.00638	CcSEcCtD
Saxagliptin—Oedema peripheral—Tamoxifen—pancreatic cancer	0.00109	0.00632	CcSEcCtD
Saxagliptin—Face oedema—Gemcitabine—pancreatic cancer	0.00106	0.00615	CcSEcCtD
Saxagliptin—Blood creatinine increased—Irinotecan—pancreatic cancer	0.00106	0.00613	CcSEcCtD
Saxagliptin—Infestation NOS—Sunitinib—pancreatic cancer	0.00106	0.00612	CcSEcCtD
Saxagliptin—Infestation—Sunitinib—pancreatic cancer	0.00106	0.00612	CcSEcCtD
Saxagliptin—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.00103	0.00597	CcSEcCtD
Saxagliptin—Urinary tract infection—Sunitinib—pancreatic cancer	0.00103	0.00595	CcSEcCtD
Saxagliptin—SLCO4C1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00102	0.0267	CbGpPWpGaD
Saxagliptin—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.000967	0.0056	CcSEcCtD
Saxagliptin—Pancreatitis—Irinotecan—pancreatic cancer	0.000956	0.00554	CcSEcCtD
Saxagliptin—Malnutrition—Erlotinib—pancreatic cancer	0.000953	0.00552	CcSEcCtD
Saxagliptin—Flatulence—Erlotinib—pancreatic cancer	0.000939	0.00544	CcSEcCtD
Saxagliptin—Oedema peripheral—Sunitinib—pancreatic cancer	0.000934	0.00541	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.000906	0.00525	CcSEcCtD
Saxagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—pancreatic cancer	0.000898	0.0235	CbGpPWpGaD
Saxagliptin—Angioedema—Tamoxifen—pancreatic cancer	0.00088	0.0051	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000868	0.00503	CcSEcCtD
Saxagliptin—Immune system disorder—Sunitinib—pancreatic cancer	0.000856	0.00496	CcSEcCtD
Saxagliptin—Infestation NOS—Fluorouracil—pancreatic cancer	0.000833	0.00483	CcSEcCtD
Saxagliptin—Infestation—Fluorouracil—pancreatic cancer	0.000833	0.00483	CcSEcCtD
Saxagliptin—Malnutrition—Sunitinib—pancreatic cancer	0.000825	0.00478	CcSEcCtD
Saxagliptin—Arthralgia—Tamoxifen—pancreatic cancer	0.00082	0.00475	CcSEcCtD
Saxagliptin—Myalgia—Tamoxifen—pancreatic cancer	0.00082	0.00475	CcSEcCtD
Saxagliptin—Flatulence—Sunitinib—pancreatic cancer	0.000813	0.00471	CcSEcCtD
Saxagliptin—Myalgia—Erlotinib—pancreatic cancer	0.000811	0.0047	CcSEcCtD
Saxagliptin—Arthralgia—Erlotinib—pancreatic cancer	0.000811	0.0047	CcSEcCtD
Saxagliptin—Urinary tract infection—Fluorouracil—pancreatic cancer	0.00081	0.00469	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000806	0.00467	CcSEcCtD
Saxagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—pancreatic cancer	0.000799	0.0209	CbGpPWpGaD
Saxagliptin—Sinusitis—Fluorouracil—pancreatic cancer	0.000781	0.00453	CcSEcCtD
Saxagliptin—Infection—Tamoxifen—pancreatic cancer	0.000781	0.00453	CcSEcCtD
Saxagliptin—Infection—Erlotinib—pancreatic cancer	0.000773	0.00448	CcSEcCtD
Saxagliptin—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00077	0.00446	CcSEcCtD
Saxagliptin—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000762	0.00441	CcSEcCtD
Saxagliptin—Skin disorder—Erlotinib—pancreatic cancer	0.000756	0.00438	CcSEcCtD
Saxagliptin—Angioedema—Sunitinib—pancreatic cancer	0.000754	0.00437	CcSEcCtD
Saxagliptin—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000749	0.00434	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000716	0.00415	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000709	0.00411	CcSEcCtD
Saxagliptin—Immune system disorder—Irinotecan—pancreatic cancer	0.000705	0.00409	CcSEcCtD
Saxagliptin—Arthralgia—Sunitinib—pancreatic cancer	0.000702	0.00407	CcSEcCtD
Saxagliptin—Myalgia—Sunitinib—pancreatic cancer	0.000702	0.00407	CcSEcCtD
Saxagliptin—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000698	0.00404	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000698	0.00404	CcSEcCtD
Saxagliptin—Dyspepsia—Tamoxifen—pancreatic cancer	0.000692	0.00401	CcSEcCtD
Saxagliptin—Immune system disorder—Gemcitabine—pancreatic cancer	0.000687	0.00398	CcSEcCtD
Saxagliptin—Dyspepsia—Erlotinib—pancreatic cancer	0.000685	0.00397	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000679	0.00393	CcSEcCtD
Saxagliptin—Fatigue—Tamoxifen—pancreatic cancer	0.000678	0.00393	CcSEcCtD
Saxagliptin—DPP4—Peptide hormone metabolism—GCG—pancreatic cancer	0.000672	0.0175	CbGpPWpGaD
Saxagliptin—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000672	0.00389	CcSEcCtD
Saxagliptin—Fatigue—Erlotinib—pancreatic cancer	0.000671	0.00389	CcSEcCtD
Saxagliptin—Flatulence—Irinotecan—pancreatic cancer	0.00067	0.00388	CcSEcCtD
Saxagliptin—Infection—Sunitinib—pancreatic cancer	0.000669	0.00388	CcSEcCtD
Saxagliptin—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000659	0.00382	CcSEcCtD
Saxagliptin—Skin disorder—Sunitinib—pancreatic cancer	0.000654	0.00379	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000643	0.00373	CcSEcCtD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000636	0.0166	CbGpPWpGaD
Saxagliptin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000636	0.00369	CcSEcCtD
Saxagliptin—Urticaria—Tamoxifen—pancreatic cancer	0.000625	0.00362	CcSEcCtD
Saxagliptin—Abdominal pain—Tamoxifen—pancreatic cancer	0.000621	0.0036	CcSEcCtD
Saxagliptin—Abdominal pain—Erlotinib—pancreatic cancer	0.000615	0.00356	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000613	0.00356	CcSEcCtD
Saxagliptin—Infestation NOS—Docetaxel—pancreatic cancer	0.000601	0.00348	CcSEcCtD
Saxagliptin—Infestation—Docetaxel—pancreatic cancer	0.000601	0.00348	CcSEcCtD
Saxagliptin—Dyspepsia—Sunitinib—pancreatic cancer	0.000593	0.00344	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000581	0.00337	CcSEcCtD
Saxagliptin—Fatigue—Sunitinib—pancreatic cancer	0.000581	0.00336	CcSEcCtD
Saxagliptin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000579	0.00336	CcSEcCtD
Saxagliptin—Asthenia—Tamoxifen—pancreatic cancer	0.000564	0.00327	CcSEcCtD
Saxagliptin—Arthralgia—Gemcitabine—pancreatic cancer	0.000564	0.00327	CcSEcCtD
Saxagliptin—Myalgia—Gemcitabine—pancreatic cancer	0.000564	0.00327	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00056	0.00324	CcSEcCtD
Saxagliptin—Asthenia—Erlotinib—pancreatic cancer	0.000558	0.00323	CcSEcCtD
Saxagliptin—Pruritus—Tamoxifen—pancreatic cancer	0.000556	0.00322	CcSEcCtD
Saxagliptin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000555	0.00321	CcSEcCtD
Saxagliptin—Myalgia—Fluorouracil—pancreatic cancer	0.000554	0.00321	CcSEcCtD
Saxagliptin—Infection—Irinotecan—pancreatic cancer	0.000551	0.00319	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000551	0.00319	CcSEcCtD
Saxagliptin—Pruritus—Erlotinib—pancreatic cancer	0.00055	0.00319	CcSEcCtD
Saxagliptin—Purpura—Epirubicin—pancreatic cancer	0.000546	0.00316	CcSEcCtD
Saxagliptin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	0.000545	0.0142	CbGpPWpGaD
Saxagliptin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000543	0.00315	CcSEcCtD
Saxagliptin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00054	0.00313	CcSEcCtD
Saxagliptin—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000539	0.00312	CcSEcCtD
Saxagliptin—Infection—Gemcitabine—pancreatic cancer	0.000537	0.00311	CcSEcCtD
Saxagliptin—Abdominal pain—Sunitinib—pancreatic cancer	0.000532	0.00308	CcSEcCtD
Saxagliptin—Oedema peripheral—Docetaxel—pancreatic cancer	0.000532	0.00308	CcSEcCtD
Saxagliptin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000531	0.00308	CcSEcCtD
Saxagliptin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000529	0.00307	CcSEcCtD
Saxagliptin—Infection—Fluorouracil—pancreatic cancer	0.000528	0.00306	CcSEcCtD
Saxagliptin—Skin disorder—Gemcitabine—pancreatic cancer	0.000525	0.00304	CcSEcCtD
Saxagliptin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00052	0.00301	CcSEcCtD
Saxagliptin—Dizziness—Tamoxifen—pancreatic cancer	0.00052	0.00301	CcSEcCtD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000519	0.0136	CbGpPWpGaD
Saxagliptin—Dizziness—Erlotinib—pancreatic cancer	0.000514	0.00298	CcSEcCtD
Saxagliptin—Face oedema—Epirubicin—pancreatic cancer	0.000508	0.00294	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—pancreatic cancer	0.000505	0.00293	CcSEcCtD
Saxagliptin—ABCC1—S1P1 pathway—KDR—pancreatic cancer	0.000502	0.0131	CbGpPWpGaD
Saxagliptin—Vomiting—Tamoxifen—pancreatic cancer	0.0005	0.0029	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000499	0.00289	CcSEcCtD
Saxagliptin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000496	0.00288	CcSEcCtD
Saxagliptin—Rash—Tamoxifen—pancreatic cancer	0.000496	0.00287	CcSEcCtD
Saxagliptin—Dermatitis—Tamoxifen—pancreatic cancer	0.000495	0.00287	CcSEcCtD
Saxagliptin—Vomiting—Erlotinib—pancreatic cancer	0.000495	0.00287	CcSEcCtD
Saxagliptin—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000493	0.00286	CcSEcCtD
Saxagliptin—Headache—Tamoxifen—pancreatic cancer	0.000493	0.00285	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000492	0.00285	CcSEcCtD
Saxagliptin—Rash—Erlotinib—pancreatic cancer	0.00049	0.00284	CcSEcCtD
Saxagliptin—Dermatitis—Erlotinib—pancreatic cancer	0.00049	0.00284	CcSEcCtD
Saxagliptin—Dyspepsia—Irinotecan—pancreatic cancer	0.000488	0.00283	CcSEcCtD
Saxagliptin—Immune system disorder—Docetaxel—pancreatic cancer	0.000487	0.00283	CcSEcCtD
Saxagliptin—Headache—Erlotinib—pancreatic cancer	0.000487	0.00282	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000484	0.0028	CcSEcCtD
Saxagliptin—Asthenia—Sunitinib—pancreatic cancer	0.000483	0.0028	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000479	0.00278	CcSEcCtD
Saxagliptin—Fatigue—Irinotecan—pancreatic cancer	0.000478	0.00277	CcSEcCtD
Saxagliptin—Pruritus—Sunitinib—pancreatic cancer	0.000476	0.00276	CcSEcCtD
Saxagliptin—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000471	0.00273	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—pancreatic cancer	0.00047	0.00272	CcSEcCtD
Saxagliptin—Malnutrition—Docetaxel—pancreatic cancer	0.00047	0.00272	CcSEcCtD
Saxagliptin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000468	0.00271	CcSEcCtD
Saxagliptin—Nausea—Tamoxifen—pancreatic cancer	0.000467	0.00271	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000466	0.0027	CcSEcCtD
Saxagliptin—Fatigue—Gemcitabine—pancreatic cancer	0.000466	0.0027	CcSEcCtD
Saxagliptin—Gastritis—Epirubicin—pancreatic cancer	0.000466	0.0027	CcSEcCtD
Saxagliptin—Nausea—Erlotinib—pancreatic cancer	0.000462	0.00268	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000459	0.00266	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000456	0.00264	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000454	0.00263	CcSEcCtD
Saxagliptin—Pancreatitis—Epirubicin—pancreatic cancer	0.000446	0.00258	CcSEcCtD
Saxagliptin—Dizziness—Sunitinib—pancreatic cancer	0.000445	0.00258	CcSEcCtD
Saxagliptin—Abdominal pain—Irinotecan—pancreatic cancer	0.000438	0.00254	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000435	0.00252	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—pancreatic cancer	0.000431	0.0025	CcSEcCtD
Saxagliptin—SLC22A8—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000429	0.0112	CbGpPWpGaD
Saxagliptin—Vomiting—Sunitinib—pancreatic cancer	0.000428	0.00248	CcSEcCtD
Saxagliptin—Rash—Sunitinib—pancreatic cancer	0.000425	0.00246	CcSEcCtD
Saxagliptin—Dermatitis—Sunitinib—pancreatic cancer	0.000424	0.00246	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000423	0.00245	CcSEcCtD
Saxagliptin—Urticaria—Fluorouracil—pancreatic cancer	0.000422	0.00245	CcSEcCtD
Saxagliptin—Headache—Sunitinib—pancreatic cancer	0.000422	0.00244	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000413	0.00239	CcSEcCtD
Saxagliptin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000409	0.00237	CcSEcCtD
Saxagliptin—Infestation NOS—Epirubicin—pancreatic cancer	0.000405	0.00235	CcSEcCtD
Saxagliptin—Infestation—Epirubicin—pancreatic cancer	0.000405	0.00235	CcSEcCtD
Saxagliptin—Arthralgia—Docetaxel—pancreatic cancer	0.0004	0.00232	CcSEcCtD
Saxagliptin—Myalgia—Docetaxel—pancreatic cancer	0.0004	0.00232	CcSEcCtD
Saxagliptin—Nausea—Sunitinib—pancreatic cancer	0.0004	0.00232	CcSEcCtD
Saxagliptin—Asthenia—Irinotecan—pancreatic cancer	0.000398	0.00231	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000397	0.0023	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—FUT8—pancreatic cancer	0.000395	0.0103	CbGpPWpGaD
Saxagliptin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000394	0.00228	CcSEcCtD
Saxagliptin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000391	0.00227	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000391	0.00227	CcSEcCtD
Saxagliptin—Asthenia—Gemcitabine—pancreatic cancer	0.000388	0.00225	CcSEcCtD
Saxagliptin—SLCO4C1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000386	0.0101	CbGpPWpGaD
Saxagliptin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000383	0.00222	CcSEcCtD
Saxagliptin—Pruritus—Gemcitabine—pancreatic cancer	0.000382	0.00222	CcSEcCtD
Saxagliptin—Infection—Docetaxel—pancreatic cancer	0.000381	0.00221	CcSEcCtD
Saxagliptin—Sinusitis—Epirubicin—pancreatic cancer	0.00038	0.0022	CcSEcCtD
Saxagliptin—Pruritus—Fluorouracil—pancreatic cancer	0.000376	0.00218	CcSEcCtD
Saxagliptin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000375	0.00218	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—pancreatic cancer	0.000375	0.00217	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000375	0.00217	CcSEcCtD
Saxagliptin—Skin disorder—Docetaxel—pancreatic cancer	0.000372	0.00216	CcSEcCtD
Saxagliptin—Dizziness—Irinotecan—pancreatic cancer	0.000367	0.00213	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000365	0.00211	CcSEcCtD
Saxagliptin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000359	0.00208	CcSEcCtD
Saxagliptin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000356	0.00931	CbGpPWpGaD
Saxagliptin—Vomiting—Irinotecan—pancreatic cancer	0.000353	0.00204	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—pancreatic cancer	0.000352	0.00204	CcSEcCtD
Saxagliptin—Dizziness—Fluorouracil—pancreatic cancer	0.000351	0.00204	CcSEcCtD
Saxagliptin—ABCC1—S1P1 pathway—PTGS2—pancreatic cancer	0.000351	0.00917	CbGpPWpGaD
Saxagliptin—Rash—Irinotecan—pancreatic cancer	0.00035	0.00203	CcSEcCtD
Saxagliptin—Dermatitis—Irinotecan—pancreatic cancer	0.000349	0.00202	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000349	0.00202	CcSEcCtD
Saxagliptin—Headache—Irinotecan—pancreatic cancer	0.000347	0.00201	CcSEcCtD
Saxagliptin—Vomiting—Gemcitabine—pancreatic cancer	0.000344	0.00199	CcSEcCtD
Saxagliptin—Rash—Gemcitabine—pancreatic cancer	0.000341	0.00197	CcSEcCtD
Saxagliptin—Dermatitis—Gemcitabine—pancreatic cancer	0.00034	0.00197	CcSEcCtD
Saxagliptin—Headache—Gemcitabine—pancreatic cancer	0.000338	0.00196	CcSEcCtD
Saxagliptin—Vomiting—Fluorouracil—pancreatic cancer	0.000338	0.00196	CcSEcCtD
Saxagliptin—Dyspepsia—Docetaxel—pancreatic cancer	0.000338	0.00196	CcSEcCtD
Saxagliptin—Rash—Fluorouracil—pancreatic cancer	0.000335	0.00194	CcSEcCtD
Saxagliptin—Dermatitis—Fluorouracil—pancreatic cancer	0.000335	0.00194	CcSEcCtD
Saxagliptin—Headache—Fluorouracil—pancreatic cancer	0.000333	0.00193	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000332	0.00192	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000331	0.00192	CcSEcCtD
Saxagliptin—Fatigue—Docetaxel—pancreatic cancer	0.000331	0.00192	CcSEcCtD
Saxagliptin—Nausea—Irinotecan—pancreatic cancer	0.000329	0.00191	CcSEcCtD
Saxagliptin—Immune system disorder—Epirubicin—pancreatic cancer	0.000329	0.00191	CcSEcCtD
Saxagliptin—Nausea—Gemcitabine—pancreatic cancer	0.000321	0.00186	CcSEcCtD
Saxagliptin—Malnutrition—Epirubicin—pancreatic cancer	0.000317	0.00184	CcSEcCtD
Saxagliptin—Nausea—Fluorouracil—pancreatic cancer	0.000316	0.00183	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000314	0.00182	CcSEcCtD
Saxagliptin—Flatulence—Epirubicin—pancreatic cancer	0.000312	0.00181	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000304	0.00176	CcSEcCtD
Saxagliptin—Abdominal pain—Docetaxel—pancreatic cancer	0.000303	0.00176	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—pancreatic cancer	0.000293	0.0017	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—pancreatic cancer	0.000289	0.00167	CcSEcCtD
Saxagliptin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000282	0.00164	CcSEcCtD
Saxagliptin—ABCC1—S1P1 pathway—VEGFA—pancreatic cancer	0.000277	0.00723	CbGpPWpGaD
Saxagliptin—Asthenia—Docetaxel—pancreatic cancer	0.000275	0.00159	CcSEcCtD
Saxagliptin—Pruritus—Docetaxel—pancreatic cancer	0.000271	0.00157	CcSEcCtD
Saxagliptin—DPP4—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.000271	0.00707	CbGpPWpGaD
Saxagliptin—Arthralgia—Epirubicin—pancreatic cancer	0.00027	0.00156	CcSEcCtD
Saxagliptin—Myalgia—Epirubicin—pancreatic cancer	0.00027	0.00156	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000268	0.00155	CcSEcCtD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000267	0.00698	CbGpPWpGaD
Saxagliptin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000259	0.0015	CcSEcCtD
Saxagliptin—Infection—Epirubicin—pancreatic cancer	0.000257	0.00149	CcSEcCtD
Saxagliptin—Dizziness—Docetaxel—pancreatic cancer	0.000254	0.00147	CcSEcCtD
Saxagliptin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000253	0.00147	CcSEcCtD
Saxagliptin—Skin disorder—Epirubicin—pancreatic cancer	0.000251	0.00146	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—pancreatic cancer	0.00025	0.00145	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—pancreatic cancer	0.00025	0.00145	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000248	0.00144	CcSEcCtD
Saxagliptin—Vomiting—Docetaxel—pancreatic cancer	0.000244	0.00141	CcSEcCtD
Saxagliptin—Rash—Docetaxel—pancreatic cancer	0.000242	0.0014	CcSEcCtD
Saxagliptin—Dermatitis—Docetaxel—pancreatic cancer	0.000242	0.0014	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—PCSK1—pancreatic cancer	0.000241	0.0063	CbGpPWpGaD
Saxagliptin—Headache—Docetaxel—pancreatic cancer	0.00024	0.00139	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000239	0.00139	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—pancreatic cancer	0.000238	0.00138	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000236	0.00137	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000234	0.00136	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—pancreatic cancer	0.000232	0.00135	CcSEcCtD
Saxagliptin—Nausea—Docetaxel—pancreatic cancer	0.000228	0.00132	CcSEcCtD
Saxagliptin—Dyspepsia—Epirubicin—pancreatic cancer	0.000228	0.00132	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000223	0.00129	CcSEcCtD
Saxagliptin—Fatigue—Epirubicin—pancreatic cancer	0.000223	0.00129	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000221	0.00577	CbGpPWpGaD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000218	0.00126	CcSEcCtD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000218	0.00569	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000214	0.00558	CbGpPWpGaD
Saxagliptin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000211	0.00123	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000211	0.00122	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000207	0.0012	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—pancreatic cancer	0.000206	0.0012	CcSEcCtD
Saxagliptin—Urticaria—Epirubicin—pancreatic cancer	0.000205	0.00119	CcSEcCtD
Saxagliptin—Abdominal pain—Epirubicin—pancreatic cancer	0.000204	0.00118	CcSEcCtD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000196	0.00512	CbGpPWpGaD
Saxagliptin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000196	0.00113	CcSEcCtD
Saxagliptin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000191	0.0011	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—pancreatic cancer	0.00019	0.0011	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000189	0.0011	CcSEcCtD
Saxagliptin—Asthenia—Epirubicin—pancreatic cancer	0.000186	0.00108	CcSEcCtD
Saxagliptin—Pruritus—Epirubicin—pancreatic cancer	0.000183	0.00106	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000176	0.00102	CcSEcCtD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000174	0.00455	CbGpPWpGaD
Saxagliptin—Asthenia—Doxorubicin—pancreatic cancer	0.000172	0.000995	CcSEcCtD
Saxagliptin—Dizziness—Epirubicin—pancreatic cancer	0.000171	0.000991	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—pancreatic cancer	0.000169	0.000981	CcSEcCtD
Saxagliptin—Vomiting—Epirubicin—pancreatic cancer	0.000164	0.000953	CcSEcCtD
Saxagliptin—Rash—Epirubicin—pancreatic cancer	0.000163	0.000945	CcSEcCtD
Saxagliptin—Dermatitis—Epirubicin—pancreatic cancer	0.000163	0.000944	CcSEcCtD
Saxagliptin—Headache—Epirubicin—pancreatic cancer	0.000162	0.000939	CcSEcCtD
Saxagliptin—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000162	0.00423	CbGpPWpGaD
Saxagliptin—ABCC1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000162	0.00423	CbGpPWpGaD
Saxagliptin—Dizziness—Doxorubicin—pancreatic cancer	0.000158	0.000917	CcSEcCtD
Saxagliptin—Nausea—Epirubicin—pancreatic cancer	0.000154	0.00089	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—pancreatic cancer	0.000152	0.000882	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—pancreatic cancer	0.000151	0.000874	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—pancreatic cancer	0.000151	0.000874	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—pancreatic cancer	0.00015	0.000869	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—pancreatic cancer	0.000142	0.000824	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—GCG—pancreatic cancer	0.000127	0.00331	CbGpPWpGaD
Saxagliptin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—pancreatic cancer	0.000104	0.00272	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	8.23e-05	0.00215	CbGpPWpGaD
Saxagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	8.22e-05	0.00215	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—MMP2—pancreatic cancer	6.67e-05	0.00174	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.58e-05	0.00172	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PRSS1—pancreatic cancer	6.45e-05	0.00168	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ZNRF3—pancreatic cancer	6.45e-05	0.00168	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—DTX1—pancreatic cancer	5.83e-05	0.00152	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—CXCL8—pancreatic cancer	5.54e-05	0.00145	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PRSS1—pancreatic cancer	5.4e-05	0.00141	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—CTNNB1—pancreatic cancer	5.11e-05	0.00134	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—DTX4—pancreatic cancer	4.89e-05	0.00128	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PPP2R5B—pancreatic cancer	4.76e-05	0.00124	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ARG2—pancreatic cancer	4.68e-05	0.00122	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HEY2—pancreatic cancer	4.58e-05	0.0012	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HEY1—pancreatic cancer	4.24e-05	0.00111	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—TYMP—pancreatic cancer	4.09e-05	0.00107	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—JAG2—pancreatic cancer	3.76e-05	0.000982	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MEN1—pancreatic cancer	3.7e-05	0.000968	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SLC2A2—pancreatic cancer	3.68e-05	0.000961	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SHH—pancreatic cancer	3.53e-05	0.000923	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—IAPP—pancreatic cancer	3.49e-05	0.000912	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PRSS1—pancreatic cancer	3.41e-05	0.00089	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.38e-05	0.000882	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HSPA1B—pancreatic cancer	3.35e-05	0.000875	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GLP1R—pancreatic cancer	3.3e-05	0.000862	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—DPYD—pancreatic cancer	3.25e-05	0.000848	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—SLC2A2—pancreatic cancer	3.08e-05	0.000805	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.05e-05	0.000796	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—JAG1—pancreatic cancer	3e-05	0.000783	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ARG2—pancreatic cancer	2.95e-05	0.000771	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.94e-05	0.000769	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CD44—pancreatic cancer	2.85e-05	0.000744	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HSPA1A—pancreatic cancer	2.83e-05	0.000739	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.68e-05	0.0007	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—TYMP—pancreatic cancer	2.58e-05	0.000674	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CD44—pancreatic cancer	2.39e-05	0.000623	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.34e-05	0.00061	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.31e-05	0.000605	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GCG—pancreatic cancer	2.29e-05	0.000597	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SMAD4—pancreatic cancer	2.25e-05	0.000587	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HES1—pancreatic cancer	2.2e-05	0.000574	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—STK11—pancreatic cancer	2.15e-05	0.000562	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GLP1R—pancreatic cancer	2.08e-05	0.000543	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—DPYD—pancreatic cancer	2.05e-05	0.000535	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.02e-05	0.000527	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.94e-05	0.000507	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TERT—pancreatic cancer	1.92e-05	0.000503	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—TYMS—pancreatic cancer	1.85e-05	0.000483	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HIF1A—pancreatic cancer	1.84e-05	0.000481	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TSC2—pancreatic cancer	1.84e-05	0.000479	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—APOE—pancreatic cancer	1.8e-05	0.000469	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—NOTCH1—pancreatic cancer	1.66e-05	0.000433	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—EGF—pancreatic cancer	1.6e-05	0.000419	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.58e-05	0.000414	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—APOE—pancreatic cancer	1.5e-05	0.000393	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CD44—pancreatic cancer	1.5e-05	0.000393	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GCG—pancreatic cancer	1.44e-05	0.000377	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PIK3CD—pancreatic cancer	1.43e-05	0.000372	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.42e-05	0.000372	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.37e-05	0.000359	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CG—pancreatic cancer	1.36e-05	0.000355	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—STK11—pancreatic cancer	1.36e-05	0.000354	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PPARG—pancreatic cancer	1.31e-05	0.000342	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PIK3CB—pancreatic cancer	1.24e-05	0.000324	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PTGS2—pancreatic cancer	1.23e-05	0.000322	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.2e-05	0.000313	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CD—pancreatic cancer	1.19e-05	0.000312	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.17e-05	0.000305	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CTNNB1—pancreatic cancer	1.1e-05	0.000288	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PTEN—pancreatic cancer	1.07e-05	0.00028	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CB—pancreatic cancer	1.04e-05	0.000272	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PTGS2—pancreatic cancer	1.03e-05	0.000269	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SRC—pancreatic cancer	9.95e-06	0.00026	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.67e-06	0.000253	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—STAT3—pancreatic cancer	9.6e-06	0.000251	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—NRAS—pancreatic cancer	9.58e-06	0.00025	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.52e-06	0.000249	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—APOE—pancreatic cancer	9.48e-06	0.000248	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.03e-06	0.000236	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PTEN—pancreatic cancer	8.99e-06	0.000235	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MYC—pancreatic cancer	8.92e-06	0.000233	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TGFB1—pancreatic cancer	8.9e-06	0.000232	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—EGFR—pancreatic cancer	8.73e-06	0.000228	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	8.56e-06	0.000224	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PPARG—pancreatic cancer	8.26e-06	0.000216	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—KRAS—pancreatic cancer	8.24e-06	0.000215	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PIK3CA—pancreatic cancer	7.57e-06	0.000198	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	7.52e-06	0.000197	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HRAS—pancreatic cancer	7.01e-06	0.000183	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CD44—pancreatic cancer	6.99e-06	0.000183	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GCG—pancreatic cancer	6.7e-06	0.000175	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	6.56e-06	0.000171	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PTGS2—pancreatic cancer	6.5e-06	0.00017	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CA—pancreatic cancer	6.34e-06	0.000166	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—STK11—pancreatic cancer	6.3e-06	0.000165	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—AKT1—pancreatic cancer	6.19e-06	0.000162	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PTEN—pancreatic cancer	5.67e-06	0.000148	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.42e-06	0.000142	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—AKT1—pancreatic cancer	5.18e-06	0.000135	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—APOE—pancreatic cancer	4.41e-06	0.000115	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	4e-06	0.000104	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.98e-06	0.000104	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.84e-06	0.0001	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.5e-06	9.14e-05	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—AKT1—pancreatic cancer	3.27e-06	8.53e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.05e-06	7.96e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.02e-06	7.89e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.63e-06	6.88e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.86e-06	4.86e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.52e-06	3.97e-05	CbGpPWpGaD
